TVTX logo

Travere Therapeutics, Inc. (TVTX) return on assets

Annual ROA:

-46.37%+5.13%(+9.96%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TVTX annual return on assets is -46.37%, with the most recent change of +5.13% (+9.96%) on December 31, 2024.
  • During the last 3 years, TVTX annual ROA has fallen by -20.35% (-78.21%).
  • TVTX annual ROA is now -234.06% below its all-time high of 34.59%, reached on December 31, 2015.

Performance

TVTX ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXprofitability metrics

Quarterly ROA:

-30.69%+8.78%(+22.24%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX quarterly return on assets is -30.69%, with the most recent change of +8.78% (+22.24%) on June 30, 2025.
  • Over the past year, TVTX quarterly ROA has increased by +22.97% (+42.81%).
  • TVTX quarterly ROA is now -204.74% below its all-time high of 29.30%, reached on December 31, 2015.

Performance

TVTX Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXprofitability metrics

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

TVTX ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+10.0%+42.8%
3 y3 years-78.2%-4.1%
5 y5 years-113.2%-108.1%

TVTX ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-78.2%+10.0%-4.1%+42.8%
5 y5-year-113.2%+10.0%-148.7%+42.8%
alltimeall time-234.1%+98.2%-204.7%+99.5%

TVTX ROA History

DateAnnualQuarterly
Jun 2025
-
-30.69%(-22.2%)
Mar 2025
-
-39.47%(-23.6%)
Dec 2024
-46.37%(-10.0%)
-51.68%(-1.1%)
Sep 2024
-
-52.23%(-2.7%)
Jun 2024
-
-53.66%(+2.9%)
Mar 2024
-
-52.14%(+11.2%)
Dec 2023
-51.50%(+12.6%)
-46.89%(-0.8%)
Sep 2023
-
-47.28%(+0.0%)
Jun 2023
-
-47.26%(+8.2%)
Mar 2023
-
-43.68%(+5.7%)
Dec 2022
-45.74%(+75.8%)
-41.33%(+15.3%)
Sep 2022
-
-35.85%(+21.6%)
Jun 2022
-
-29.47%(+13.4%)
Mar 2022
-
-25.98%(+5.9%)
Dec 2021
-26.02%(-6.9%)
-24.54%(-29.6%)
Sep 2021
-
-34.88%(+2.7%)
Jun 2021
-
-33.97%(+0.5%)
Mar 2021
-
-33.80%(+25.9%)
Dec 2020
-27.95%(+28.5%)
-26.84%(+117.5%)
Sep 2020
-
-12.34%(-16.3%)
Jun 2020
-
-14.75%(-12.4%)
Mar 2020
-
-16.84%(-24.7%)
Dec 2019
-21.75%(+35.4%)
-22.35%(+22.5%)
Sep 2019
-
-18.25%(-15.9%)
Jun 2019
-
-21.70%(+8.0%)
Mar 2019
-
-20.09%(+16.9%)
Dec 2018
-16.06%(+48.6%)
-17.19%(-15.7%)
Sep 2018
-
-20.40%(+37.0%)
Jun 2018
-
-14.89%(+14.5%)
Mar 2018
-
-13.01%(+15.1%)
Dec 2017
-10.81%
-11.30%(+17.6%)
Sep 2017
-
-9.61%(-27.3%)
Jun 2017
-
-13.21%(-0.2%)
DateAnnualQuarterly
Mar 2017
-
-13.24%(+46.6%)
Dec 2016
-8.63%(-124.9%)
-9.03%(+12.3%)
Sep 2016
-
-8.04%(-139.7%)
Jun 2016
-
20.26%(+8.2%)
Mar 2016
-
18.72%(-36.1%)
Dec 2015
34.59%(-124.3%)
29.30%(+5.6%)
Sep 2015
-
27.74%(-305.8%)
Jun 2015
-
-13.48%(+5516.7%)
Mar 2015
-
-0.24%(-99.8%)
Dec 2014
-142.26%(-53.0%)
-100.39%(-7.1%)
Sep 2014
-
-108.05%(-26.0%)
Jun 2014
-
-145.97%(-57.8%)
Mar 2014
-
-346.24%(+7.2%)
Dec 2013
-302.53%(-88.1%)
-322.98%(-60.3%)
Sep 2013
-
-812.90%(-59.4%)
Jun 2013
-
-2001.97%(-16.1%)
Mar 2013
-
-2385.44%(-62.2%)
Dec 2012
-2533.62%(+373.7%)
-6303.24%(+1644.2%)
Nov 2011
-
-361.39%(-10.1%)
Aug 2011
-
-401.91%(-12.8%)
May 2011
-
-460.65%(-10.7%)
Feb 2011
-534.88%(-10.2%)
-515.70%(-8.4%)
Nov 2010
-
-563.04%(-2.5%)
Aug 2010
-
-577.59%(+0.5%)
May 2010
-
-574.79%(-2.8%)
Feb 2010
-595.74%(-21.9%)
-591.10%(-1.3%)
Nov 2009
-
-598.74%(+10.1%)
Aug 2009
-
-543.57%(+17.4%)
May 2009
-
-463.11%(+23.3%)
Feb 2009
-762.50%
-375.51%(+71.5%)
Nov 2008
-
-218.92%(+68.4%)
Aug 2008
-
-130.00%(+91.2%)
May 2008
-
-68.00%

FAQ

  • What is Travere Therapeutics, Inc. annual return on assets?
  • What is the all time high annual ROA for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual ROA year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly return on assets?
  • What is the all time high quarterly ROA for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly ROA year-on-year change?

What is Travere Therapeutics, Inc. annual return on assets?

The current annual ROA of TVTX is -46.37%

What is the all time high annual ROA for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual return on assets is 34.59%

What is Travere Therapeutics, Inc. annual ROA year-on-year change?

Over the past year, TVTX annual return on assets has changed by +5.13% (+9.96%)

What is Travere Therapeutics, Inc. quarterly return on assets?

The current quarterly ROA of TVTX is -30.69%

What is the all time high quarterly ROA for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly return on assets is 29.30%

What is Travere Therapeutics, Inc. quarterly ROA year-on-year change?

Over the past year, TVTX quarterly return on assets has changed by +22.97% (+42.81%)
On this page